Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE. - Wikidata - wikimedia - TriplyDB

Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE.

Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE.

http://www.wikidata.org/entity/Q37063656

about

Solid Phase Immunoassay for the Detection of Anticardiolipin Antibodies.

P2860

Q53113544-7AC8FF1E-3632-4E33-B2CB-BE4504A3A144

P2860

Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE.

http://www.wikidata.org/entity/Q37063656

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Assessment of the independent ...... olipin with thrombosis in SLE.

@en

Assessment of the independent ...... olipin with thrombosis in SLE.

@nl

type

label

Assessment of the independent ...... olipin with thrombosis in SLE.

@en

Assessment of the independent ...... olipin with thrombosis in SLE.

@nl

prefLabel

Assessment of the independent ...... olipin with thrombosis in SLE.

@en

Assessment of the independent ...... olipin with thrombosis in SLE.

@nl

P1433

Q37063656-86A319AE-275D-4C36-B580-18429B60AB91

P1476

Q37063656-DDB03303-E55F-4B23-9BAE-E986C01D7416

P2093

Q37063656-0FECD5F3-8219-4EFC-AB0D-D9CA2C907574

Q37063656-D28D457A-3AF9-4E02-9048-36A77455DF9A

P2860

Q37063656-1682BA42-1A21-42B7-9027-9CF49235EBFD

Q37063656-39D60032-9855-475F-B98D-B5B25AB16B73

Q37063656-3E2F0176-583D-42F9-B6D6-B8B119435543

Q37063656-4D1637F9-D6BA-49A0-824E-21462E5A2DB1

Q37063656-51E7D72A-DD79-407E-96C4-99950ABCC0D2

Q37063656-69D9759C-9F5C-44C2-B402-70DA1181E6BE

Q37063656-81483C66-1B50-4003-94FC-1D155B704BE1

Q37063656-85408A82-BF4F-42A0-9940-1773FC743B1B

Q37063656-911ECA52-BBDC-4014-86E1-C349B9C8B696

Q37063656-91490070-E6B5-4B81-A5D5-851574DF6752

P304

Q37063656-408C0654-8CF6-49F4-A9D4-F2810068CBB2

P31

Q37063656-4033795B-DC56-49A1-9717-76ABD30EAA57

P356

Q37063656-F240660F-4F67-4BF6-8366-BE12B195BAE9

P433

Q37063656-3F9F9BAC-15AD-4E89-8A97-8AFD8DB9A818

P478

Q37063656-E4276107-ACDA-4EBE-8E8D-0F3CA8CB371C

P50

Q37063656-1962FFEA-1D77-4630-B31D-03BC5ED2E5B0

P577

Q37063656-1CDB0F07-D345-49EF-A780-0ED21EFC885B

P698

Q37063656-3D316C95-36DC-48F8-AD9E-7348CAD323CD

P921

Q37063656-2C405F98-C39C-4D04-B482-0A925CBED565

P932

Q37063656-89F7BE00-8C8C-4FB4-8093-957746968DC4

P356

LUPUS-2015-000107

P1433

Lupus science & medicine

P1476

Assessment of the independent ...... olipin with thrombosis in SLE.

@en

P2093

Laurence S Magder

http://www.w3.org/2001/XMLSchema#string

Vinicius Domingues

http://www.w3.org/2001/XMLSchema#string

P2860

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.

Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.

Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations.

Antiphospholipid syndrome: an overview.

Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome.

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.

P304

e000107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/LUPUS-2015-000107

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A. Petri

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27403332

http://www.w3.org/2001/XMLSchema#string

P921

P932

4932305

http://www.w3.org/2001/XMLSchema#string